|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Cash | |||||
| Prepaid expenses | |||||
| Total current assets | |||||
| Prepaid expenses, non-current | |||||
| Marketable securities held in Trust Account | |||||
| Total Assets | |||||
| Current liabilities: | |||||
| Accrued offering costs and expenses | |||||
| Due to related parties | |||||
| Total current liabilities | |||||
| Warrant liabilities | |||||
| Deferred underwriting discount | |||||
| Total liabilities | |||||
| Class A ordinary shares subject to possible redemption, 41,400,000 shares at redemption value of $10.00 per share, at March 31, 2022 and December 31, 2021 | |||||
| Shareholders’ Deficit: | |||||
| Class A ordinary shares, $0.0001 par value; 300,000,000 shares authorized; no shares issued and outstanding (excluding 41,400,000 shares subject to possible redemption) at March 31, 2022 and December 31, 2021 | |||||
| Class A ordinary shares | |||||
| Class B ordinary shares | |||||
| Total class A ordinary shares, $0.0001 par value; 300,000,000 shares authorized; no shares issued and outstanding (excluding 41,400,000 shares subject to possible redemption) at March 31, 2022 and December 31, 2021 | |||||
| Class B ordinary shares, $0.0001 par value; 30,000,000 shares authorized; 10,350,000 shares issued and outstanding at March 31, 2022 and December 31, 2021 | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Shareholders’ deficit | |||||
| Class A ordinary shares | |||||
| Class B ordinary shares | |||||
| Total shareholders’ deficit | |||||
| Total Liabilities, Redeemable Class A Ordinary Shares and Shareholders’ Deficit |
Loading...
